Sinopharm Group Management
Management criteria checks 4/4
Sinopharm Group's CEO is Yong Liu, appointed in Nov 2017, has a tenure of 6.42 years. total yearly compensation is CN¥6.28M, comprised of 33.1% salary and 66.9% bonuses, including company stock and options. directly owns 0.002% of the company’s shares, worth HK$1.19M. The average tenure of the management team and the board of directors is 4.3 years and 5.3 years respectively.
Key information
Yong Liu
Chief executive officer
CN¥6.3m
Total compensation
CEO salary percentage | 33.1% |
CEO tenure | 6.4yrs |
CEO ownership | 0.002% |
Management average tenure | 4.3yrs |
Board average tenure | 5.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | CN¥9b |
Sep 30 2023 | n/a | n/a | CN¥9b |
Jun 30 2023 | n/a | n/a | CN¥9b |
Mar 31 2023 | n/a | n/a | CN¥9b |
Dec 31 2022 | CN¥6m | CN¥2m | CN¥9b |
Sep 30 2022 | n/a | n/a | CN¥8b |
Jun 30 2022 | n/a | n/a | CN¥8b |
Mar 31 2022 | n/a | n/a | CN¥8b |
Dec 31 2021 | CN¥7m | CN¥2m | CN¥8b |
Sep 30 2021 | n/a | n/a | CN¥8b |
Jun 30 2021 | n/a | n/a | CN¥8b |
Mar 31 2021 | n/a | n/a | CN¥8b |
Dec 31 2020 | CN¥7m | CN¥2m | CN¥7b |
Sep 30 2020 | n/a | n/a | CN¥7b |
Jun 30 2020 | n/a | n/a | CN¥6b |
Mar 31 2020 | n/a | n/a | CN¥6b |
Dec 31 2019 | CN¥7m | CN¥2m | CN¥6b |
Sep 30 2019 | n/a | n/a | CN¥6b |
Jun 30 2019 | n/a | n/a | CN¥6b |
Mar 31 2019 | n/a | n/a | CN¥6b |
Dec 31 2018 | CN¥8m | CN¥2m | CN¥6b |
Sep 30 2018 | n/a | n/a | CN¥6b |
Jun 30 2018 | n/a | n/a | CN¥6b |
Mar 31 2018 | n/a | n/a | CN¥5b |
Dec 31 2017 | CN¥6m | CN¥1m | CN¥6b |
Compensation vs Market: Yong's total compensation ($USD866.66K) is about average for companies of similar size in the Hong Kong market ($USD924.12K).
Compensation vs Earnings: Yong's compensation has been consistent with company performance over the past year.
CEO
Yong Liu (54 yo)
6.4yrs
Tenure
CN¥6,276,000
Compensation
Mr. Yong Liu serves as the Chief Legal Advisor at Sinopharm Group Co. Ltd. and served as its Joint Company Secretary since October 28, 2016 until August 24, 2018. Mr. Liu is Executive Director of Sinopharm...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman of the Board | 5.3yrs | CN¥6.49m | 0.0032% CN¥ 2.0m | |
President & Executive Director | 6.4yrs | CN¥6.28m | 0.0019% CN¥ 1.2m | |
Chief Financial Officer | 3.1yrs | no data | no data | |
Secretary to the Board | 5.3yrs | no data | no data |
4.3yrs
Average Tenure
53.5yo
Average Age
Experienced Management: 1099's management team is considered experienced (4.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman of the Board | 5.3yrs | CN¥6.49m | 0.0032% CN¥ 2.0m | |
President & Executive Director | 6.3yrs | CN¥6.28m | 0.0019% CN¥ 1.2m | |
Non-Executive Vice Chairman | 13.9yrs | no data | no data | |
Non-Executive Director | 2.8yrs | no data | no data | |
Chief Supervisor | 2.8yrs | no data | no data | |
Non-Executive Director | 16.7yrs | no data | no data | |
Independent Non-Executive Director | 3.6yrs | CN¥350.00k | no data | |
Independent Non-Executive Director | 3.6yrs | CN¥350.00k | no data | |
Non-Executive Director | 6.6yrs | no data | no data | |
Non-Executive Director | 5.3yrs | no data | no data | |
Independent Non-Executive Director | 5.3yrs | CN¥350.00k | no data | |
Independent Non-Executive Director | 3.6yrs | CN¥350.00k | no data |
5.3yrs
Average Tenure
56yo
Average Age
Experienced Board: 1099's board of directors are considered experienced (5.3 years average tenure).